Gables Capital Management »

Outlook Therapeutics shares owned by Gables Capital Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Gables Capital Management from 13F filings

Historical chart of Gables Capital Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Gables Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Gables Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $59k 11k 5.34
2024-03-31 $116k 9.7k 11.94